Autopsy report · NCT00260494

Acupuncture and Post-Surgical Wound Healing

“No difference in primary outcomes at interim analysis.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 8 months after it had already started.
• Ran for about 1 year 4 months before it stopped.
• 65 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

University of California, San Francisco

Sponsor type

University, hospital or other

Conditions

Postoperative Complications; Surgical Wound Infection; Surgical Wound Dehiscence

Interventions

acupuncture; sham acupuncture

Participants

65

Sites

1

Countries

United States

Trials that died the same way

• In-exsufflator Cough Assist Device in Patients With Symptomatic Bronchiectasis
  “interim analysis indicates statistical futility for primary outcomes” (68% match in meaning)
• A Study of Pertuzumab in Participants With Prostate Cancer
  “The study was terminated at the time of interim analysis since none of the participants showed a PSA response.” (65% match in meaning)
• Effectiveness and Safety Study of Pentosan Polysulfate Sodium for the Treatment of Interstitial Cystitis
  “Interim Analysis showed that study continuation was futile. No safety concerns were raised during the trial.” (64% match in meaning)
• PleuraSeal Pivotal Study (US)
  “Interim analysis results were not supportive of primary endpoint” (63% match in meaning)
• A Pilot Study of Candesartan as a Treatment for Cocaine Dependence
  “Results of interim efficacy analysis showed results were not promising.” (63% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.